# Biomimetic Electrospun Silk Fibroin Scaffolds Enhance Follicle Survival and Oocyte Quality in In Vitro Culture

## Metadata

- **SPORE ID**: SPR-2026-3B4B
- **Domaines**: Tissue Regeneration x Reproductive Biology and Fertility
- **Date de generation**: 2026-08-24
- **Panel consensus score**: 6.5/10
- **Novelty score**: 0.7/1.0
- **Panel verdict**: publish_brief

## Abstract

If ovarian follicles are cultured on electrospun silk fibroin scaffolds with fiber diameter 300-600 nm, alignment 0-90 degrees, and stiffness 1-10 kPa, then follicle survival and oocyte quality will increase, because the scaffolds mimic the native ECM and provide mechanical support and biochemical cues.

The proposed mechanism involves 4 causal steps: (1) Follicles adhere to the scaffold via integrin-mediated cell-matrix interactions. -> (2) Scaffold mechanical cues activate mechanotransduction pathways (e.g., YAP/TAZ) i -> (3) These pathways upregulate expression of survival and growth factors, promoting f -> (4) The scaffold maintains 3D architecture and cell-cell communication, reducing atr.

Literature grounding on 6 verified references yields a novelty score of 0.7 (novel). A 3-phase experimental protocol (budget: €20k-80k, timeline: 8-14 months) is proposed, starting with in silico validation. A panel of 5 expert reviewers reached a consensus score of 6.5/10.

## 1. Hypothese et mecanisme propose

### 1.1 Formulation formelle

If ovarian follicles are cultured on electrospun silk fibroin scaffolds with fiber diameter 300-600 nm, alignment 0-90 degrees, and stiffness 1-10 kPa, then follicle survival and oocyte quality will increase, because the scaffolds mimic the native ECM and provide mechanical support and biochemical cues.

### 1.2 Variables

**Variables independantes :**

| Variable | Type | Plage | Unite |
|----------|------|-------|-------|
| fiber diameter | continuous | 300-600 nm | nm |
| fiber alignment | continuous | 0-90 degrees | degrees |
| scaffold stiffness | continuous | 1-10 kPa | kPa |

**Variables dependantes :**

| Variable | Type | Direction attendue | Unite |
|----------|------|-------------------|-------|
| follicle survival rate | continuous | increase | % |
| oocyte quality score | continuous | increase | score (0-100) |

### 1.3 Chaine causale

1. Step 1: Follicles adhere to the scaffold via integrin-mediated cell-matrix interactions.
1. Step 2: Scaffold mechanical cues activate mechanotransduction pathways (e.g., YAP/TAZ) in follicle cells.
1. Step 3: These pathways upregulate expression of survival and growth factors, promoting follicle viability.
1. Step 4: The scaffold maintains 3D architecture and cell-cell communication, reducing atresia and improving oocyte maturation.

**Hypotheses cles :**

- Follicle cells express integrins that bind to silk fibroin.
- The scaffold does not elicit a toxic or immune response.
- The scaffold degrades at a rate compatible with follicle development.

**Inconnues identifiees :**

- We do not know the optimal fiber diameter, alignment, and stiffness for follicle culture.
- We do not know whether the scaffold can support follicle growth to the antral stage.

### 1.4 Conditions aux limites

- **Fiber diameter must be within 300-600 nm; outside this range, cell adhesion may be compromised.** — Previous studies show optimal cell adhesion on nanofibers in this range.
- **Scaffold stiffness must be within 1-10 kPa; higher stiffness may induce differentiation or stress.** — Native ovarian tissue stiffness is in this range.
- **Culture media must be supplemented with appropriate growth factors (e.g., FSH, IGF-1).** — These factors are essential for follicle development.

### 1.5 Cadre theorique

Tissue engineering and mechanobiology

## 2. Etat de l'art et positionnement

### 2.1 Travaux les plus proches

- **[2014] Bioengineering the Ovarian Follicle Microenvironment** — [10.1146/annurev-bioeng-071813-105131](https://doi.org/10.1146/annurev-bioeng-071813-105131)
  - Similarite: related
  - Difference cle: This review discusses tissue engineering for follicle maturation but does not specifically focus on electrospun silk fibroin scaffolds or the transfer of skin wound healing principles.
- **[2023] Biomimetic natural biomaterials for tissue engineering and regenerative medicine: new biosynthesis methods, recent advances, and emerging applications** — [10.1186/s40779-023-00448-w](https://doi.org/10.1186/s40779-023-00448-w)
  - Similarite: related
  - Difference cle: This paper reviews biomimetic materials broadly but does not apply them to ovarian follicle culture.

### 2.2 Base de preuves

- **[2014] Bioengineering the Ovarian Follicle Microenvironment** — [10.1146/annurev-bioeng-071813-105131](https://doi.org/10.1146/annurev-bioeng-071813-105131)
  - Type: direct | Citations: 163
  - Directly discusses the application of tissue engineering to ovarian follicle maturation, supporting the idea of using scaffolds for follicle support.
- **[2023] Biomimetic natural biomaterials for tissue engineering and regenerative medicine: new biosynthesis methods, recent advances, and emerging applications** — [10.1186/s40779-023-00448-w](https://doi.org/10.1186/s40779-023-00448-w)
  - Type: indirect | Citations: 294
  - Supports the use of biomimetic scaffolds that mimic ECM to provide biochemical and biophysical cues, which is a key principle in the hypothesis.
- **[2020] Functionalization of Electrospun Nanofibers and Fiber Alignment Enhance Neural Stem Cell Proliferation and Neuronal Differentiation** — [10.3389/fbioe.2020.580135](https://doi.org/10.3389/fbioe.2020.580135)
  - Type: analogous | Citations: 67
  - Demonstrates that electrospun fiber alignment and functionalization enhance stem cell behavior, analogous to the proposed scaffold design for follicles.
- **[2016] A Newly Identified Mechanism Involved in Regulation of Human Mesenchymal Stem Cells by Fibrous Substrate Stiffness** — [10.1016/j.actbio.2016.06.034](https://doi.org/10.1016/j.actbio.2016.06.034)
  - Type: analogous | Citations: 54
  - Shows that substrate stiffness regulates stem cell differentiation, supporting the idea that mechanical cues from scaffolds can influence follicle cells.
- **[2025] Extracellular Matrix Signaling Cues: Biological Functions, Diseases, and Therapeutic Targets** — [10.1002/mco2.70281](https://doi.org/10.1002/mco2.70281)
  - Type: indirect | Citations: 59
  - Highlights the role of ECM mechanical properties in regulating cell behavior, supporting the importance of scaffold stiffness and architecture.
- **[2020] High Flexible and Broad Antibacterial Nanodressing Induces Complete Skin Repair with Angiogenic and Follicle Regeneration** — [10.1002/adhm.202000035](https://doi.org/10.1002/adhm.202000035)
  - Type: analogous | Citations: 51
  - Shows that silk fibroin-based scaffolds promote skin regeneration including hair follicles, suggesting similar principles could apply to ovarian follicles.

### 2.3 Contre-preuves et limitations connues

Aucune contre-preuve identifiee.

### 2.4 Evaluation de nouveaute

- **Score**: 0.7/1.0
- **Verdict**: novel

## 3. Predictions falsifiables

| # | Prediction | Borne quantitative | Methode | H0 | Test statistique |
|---|-----------|-------------------|---------|-----|-----------------|
| 1 | Follicles cultured on scaffolds with fiber diameter 300-600 nm will have a survival rate at least 20% higher than on standard 2D culture. | Survival rate increase of 20-40% after 14 days of culture | Live/dead staining and morphological assessment | H0: No significant difference in survival rate between scaffold and 2D culture. | t-test, alpha=0.05 |
| 2 | Oocyte quality score will increase by at least 15% when cultured on scaffolds with stiffness 1-10 kPa compared to stiffer substrates. | Oocyte quality score increase of 15-30% | Morphological grading and molecular markers (e.g., BMP15, GDF9) | H0: No significant difference in oocyte quality score between stiffness groups. | ANOVA, alpha=0.05 |

## 4. Protocole experimental

**Timeline globale**: 8-14 months
**Budget global**: €20k-80k

### 4.1 Phase 1 — In Silico Validation

**Objectif**: To computationally predict the optimal scaffold parameters (fiber diameter, alignment, stiffness) that maximize follicle survival and oocyte quality, and to assess the feasibility of the proposed mechanism before experimental investment.

**Methodologie**: Develop a computational model of follicle-scaffold interaction using finite element analysis (FEA) to simulate mechanical stress and strain on follicles for different scaffold stiffness and fiber alignment. Use agent-based modeling (ABM) to simulate follicle growth and survival based on mechanotransduction pathways (YAP/TAZ). Calibrate the model using existing experimental data from literature (e.g., follicle culture on hydrogels of varying stiffness). Perform parameter sweep to identify optimal ranges. Additionally, use machine learning (regression) on published datasets to correlate scaffold properties with follicle outcomes.

- Cout: €500-2000
- Duree: 4-6 weeks
- Equipement: High-performance computer (HPC) cluster or cloud computing
- Logiciels: COMSOL Multiphysics or Abaqus for FEA, NetLogo or Repast for ABM, Python with scikit-learn for ML, MATLAB for data analysis

**Criteres de succes :**

- Model predictive accuracy: R^2 > 0.7 when comparing model predictions to at least 10 published experimental data points
- Optimal parameter identification: A distinct region in parameter space where predicted survival rate increase >20% and oocyte quality score increase >15%

- **GO**: Model predictions show a clear optimal parameter region with predicted improvements meeting or exceeding the thresholds (20% survival increase, 15% oocyte quality increase) and model validation R^2 > 0.7.
- **NO-GO**: Model predicts no parameter combination achieves the desired improvements, or model validation fails (R^2 < 0.5).
- **PIVOT**: Model suggests that the mechanism is plausible but requires different parameter ranges (e.g., fiber diameter >600 nm) or additional factors (e.g., biochemical cues) to achieve improvements; then adjust hypothesis or proceed to Phase 2 with revised parameters.

### 4.2 Phase 2 — Minimal Experimental Validation

**Objectif**: To experimentally test the central hypothesis using a minimal set of conditions: compare follicle culture on silk fibroin scaffolds with a single optimal parameter set (from Phase 1) against standard 2D culture, and measure follicle survival and oocyte quality after 14 days.

**Methodologie**: Fabricate electrospun silk fibroin scaffolds with the optimal parameters identified in Phase 1 (e.g., fiber diameter ~450 nm, alignment ~45 degrees, stiffness ~5 kPa). Use a small animal model (e.g., mouse) to isolate secondary follicles (size ~100-200 µm). Culture follicles on scaffolds (experimental group) and on standard 2D culture dishes (control group) for 14 days. Use at least 3 biological replicates (each with 20-30 follicles). Assess follicle survival via live/dead staining (calcein-AM/propidium iodide) and morphological integrity (intact basement membrane, no signs of atresia). Assess oocyte quality via morphological grading (cumulus expansion, oocyte diameter) and molecular markers (BMP15, GDF9 expression via qPCR).

- Cout: €2k-15k
- Duree: 1-3 months
- Equipement: Electrospinning setup, Scanning electron microscope (SEM) for fiber characterization, Atomic force microscope (AFM) for stiffness measurement, Cell culture incubator, Fluorescence microscope, qPCR machine
- Logiciels: ImageJ for image analysis, GraphPad Prism for statistical analysis

**Criteres de succes :**

- Follicle survival rate: At least 20% higher (absolute increase) in scaffold group compared to 2D control after 14 days
- Oocyte quality score: At least 15% higher (absolute increase) in scaffold group compared to 2D control
- Mechanism activation: Significant nuclear localization of YAP/TAZ in follicle cells on scaffold vs. 2D (p<0.05)

- **GO**: Both survival and oocyte quality improvements meet or exceed thresholds, and YAP/TAZ activation is observed.
- **NO-GO**: Either survival or oocyte quality improvement is below threshold, or scaffold shows toxicity.
- **PIVOT**: If survival improves but oocyte quality does not, or vice versa, consider adjusting scaffold parameters (e.g., stiffness) or adding biochemical cues (e.g., RGD peptide) in Phase 3.

### 4.3 Phase 3 — Full Experimental Protocol

**Objectif**: To rigorously validate the hypothesis by systematically varying scaffold parameters (fiber diameter, alignment, stiffness) and assessing follicle survival and oocyte quality, with sufficient replicates and statistical power for publication.

**Methodologie**: Design a full factorial experiment with three factors: fiber diameter (3 levels: 300, 450, 600 nm), alignment (3 levels: 0, 45, 90 degrees), and stiffness (3 levels: 1, 5, 10 kPa). Include a 2D culture control and possibly a natural ECM (Matrigel) control. Use at least 5 biological replicates per condition, each with 30-50 follicles. Culture for 14 days. Assess follicle survival, oocyte quality (morphological and molecular), and also measure mechanotransduction markers (YAP/TAZ, integrin expression) and ECM degradation. Perform comprehensive statistical analysis (ANOVA, post-hoc tests, regression) to determine optimal parameter combinations and interactions. Additionally, assess long-term follicle development to antral stage and oocyte maturation (IVM) to evaluate functional outcomes.

- Cout: €15k-100k+
- Duree: 6-12 months
- Equipement: Electrospinning setup with precise control, SEM, AFM, Cell culture facilities, Confocal microscope, qPCR, Western blot, Histology equipment
- Logiciels: ImageJ, GraphPad Prism, R for statistics, Design of Experiments (DoE) software (e.g., JMP)

**Criteres de succes :**

- Main effects and interactions: Significant (p<0.05) effect of at least one scaffold parameter on survival and oocyte quality, and optimal parameter combination yields >20% survival increase and >15% oocyte quality increase over 2D control
- Mechanism validation: Correlation between YAP/TAZ activation and follicle outcomes (R>0.5, p<0.05)
- Functional outcome: Successful maturation of oocytes (metaphase II) from follicles cultured on optimal scaffold, with rates comparable to in vivo (e.g., >50%)

- **GO**: All success criteria met: significant effects, optimal parameters identified, mechanism validated, and functional oocyte maturation achieved.
- **NO-GO**: No significant improvement over 2D culture, or mechanism not validated, or oocyte maturation fails.
- **PIVOT**: If some parameters show promise but not all, refine the parameter space or incorporate biochemical cues (e.g., growth factors) into the scaffold; consider alternative materials.

### 4.4 Quick start : comment demarrer aujourd'hui

- **Peut demarrer maintenant**: Oui
- **Premiere action**: Compile a list of published datasets on follicle culture on scaffolds and mechanical properties of silk fibroin from the provided references and PubMed; create a spreadsheet of relevant data points.
- **Outils**: PubMed, Google Scholar, Excel or Google Sheets
- **Donnees ouvertes**: PubMed Central, Figshare, Dryad, Zenodo

## 5. Analyse d'impact

### 5.1 Impact scientifique

Novelty score: 0.7/1.0 (novel)

### 5.2 Applications industrielles et marche

**Score industriel**: 6.5/10

**Forces :**
- Market opportunity in fertility treatments: The global assisted reproductive technology (ART) market is projected to reach $45 billion by 2029, with a growing demand for improved in vitro fertilization (IVF) outcomes. This technology could address the unmet need for better follicle culture systems, potentially increasing success rates and reducing costs per live birth.
- Competitive advantage: The use of electrospun silk fibroin scaffolds offers a tunable biomimetic environment that mimics native ECM better than current 2D culture or Matrigel-based systems. This could lead to higher follicle survival and oocyte quality, providing a significant edge over existing products like organ-on-chip devices or traditional culture dishes.

**Faiblesses :**
- Barrier to entry: The technology is at an early TRL (3-4) with no validated clinical-grade product. Significant investment is needed for GMP-compliant scaffold manufacturing, sterilization, and regulatory approval (FDA/EMA) for clinical use, which could take 5-10 years and millions of euros.
- Commercial risk: The market for follicle culture is niche, primarily in research and fertility clinics. Adoption may be slow due to the need for specialized equipment and expertise, and reimbursement may be limited. Additionally, competition from existing 3D culture systems (e.g., alginate hydrogels) could hinder market penetration.

**Recommandation**: Proceed with Phase 1 and 2 validation, but simultaneously conduct a market analysis and engage with key opinion leaders in reproductive medicine to refine the value proposition. If Phase 2 shows promising results, consider licensing the technology to an established ART company or forming a spin-off with a clear regulatory pathway.

### 5.3 Opportunites de financement

| Programme | Agence | Fit | Budget type | Taux succes |
|-----------|--------|-----|-------------|-------------|
| ERC Starting Grant 2026 | European Research Council | 0.85 | €1.5 million over 5 years | 14% (2024 call) |
| ANR Jeunes Chercheuses et Jeunes Chercheurs (JCJC) 2025 | Agence Nationale de la Recherche (France) | 0.75 | €200k-400k over 3-4 years | 20% (2024) |
| Horizon Europe EIC Pathfinder Open 2025 | European Innovation Council | 0.65 | €3-4 million per project (lump sum) | 5-10% (2024) |

- **ERC Starting Grant 2026** (European Research Council): The hypothesis is high-risk, high-gain with a strong mechanistic basis, fitting ERC's bottom-up excellence criteria. The PI would need to demonstrate independence and track record. The budget is ample for full validation and potential translational steps.
- **ANR Jeunes Chercheuses et Jeunes Chercheurs (JCJC) 2025** (Agence Nationale de la Recherche (France)): This national grant is ideal for early-career researchers to establish their team. The project's interdisciplinary nature and clear milestones align with JCJC's objectives. The budget can support Phase 1 and 2, with potential for additional funding for Phase 3.
- **Horizon Europe EIC Pathfinder Open 2025** (European Innovation Council): The scaffold technology has potential for innovation in assisted reproduction, fitting Pathfinder's focus on breakthrough technologies. However, the TRL is low and the project may need more applied partners. The budget is generous and could support a larger consortium including clinical partners.

**Recommandation financement**: Target the ERC Starting Grant for its emphasis on high-risk, high-gain research and the PI's potential. Simultaneously, apply to the ANR Jeunes Chercheuses et Jeunes Chercheurs (JCJC) for national funding to support preliminary data. For a more applied angle, consider the Horizon Europe EIC Pathfinder Open to fund the proof-of-concept and potential innovation.

## 6. Panel Review Summary

| Reviewer | Score | Verdict | Point cle |
|----------|-------|---------|-----------|
| methodologist | 7.8/10 | accept | The protocol is well-structured with a clear three-phase approach, starting with in silico validation to de-risk experimental work, which is a strong methodological practice. |
| domain_expert | 7.0/10 | accept | The hypothesis leverages established principles of biomimetic scaffolds and mechanotransduction, which are well-supported in tissue engineering literature. |
| contrarian | 4.0/10 | weak_reject | The hypothesis addresses a clinically relevant problem (improving follicle culture) and proposes a biomimetic approach that could enhance in vitro follicle development. |
| industrialist | 6.5/10 | weak_accept | Market opportunity in fertility treatments: The global assisted reproductive technology (ART) market is projected to reach $45 billion by 2029, with a growing demand for improved in vitro fertilization (IVF) outcomes. This technology could address the unmet need for better follicle culture systems, potentially increasing success rates and reducing costs per live birth. |
| funding_strategist | 7.5/10 | accept | Clear mechanistic hypothesis with defined parameters (fiber diameter, alignment, stiffness) and measurable outcomes (follicle survival, oocyte quality). |

**Consensus score**: 6.5/10
**Verdict final**: publish_brief

### 6.1 Consensus

- The hypothesis is clinically relevant and addresses an unmet need in fertility treatments.
- The phased experimental design with clear GO/NO-GO criteria is methodologically strong.
- The use of electrospun silk fibroin scaffolds is a plausible biomimetic approach to improve follicle culture.

### 6.2 Points de desaccord

- The contrarian reviewer questions the feasibility of integrin-mediated adhesion to silk fibroin, while others assume it based on analogous systems.
- There is disagreement on the expected effect sizes and statistical power, with the contrarian suggesting they are overestimated.
- The industrialist and funding strategist have differing views on the commercial readiness and funding strategy.

### 6.3 Critical path

The most critical factor is whether follicle cells will adhere to silk fibroin scaffolds and exhibit improved survival and oocyte quality, as this underpins the entire hypothesis.

**Recommandation finale**: The panel recommends proceeding with the brief as is, but with a strong emphasis on addressing the contrarian's concerns in the experimental design. Specifically, pilot experiments should be conducted to validate follicle adhesion and viability on silk fibroin scaffolds, and to obtain preliminary data on effect sizes and variability. Additionally, randomization and blinding procedures should be explicitly incorporated, and a formal power analysis should be performed to justify sample sizes. The scaffold degradation and potential immune responses should be monitored and controlled for. With these considerations, the hypothesis has a solid foundation and warrants further investigation.

## 7. Gap Manifest residuel

### 7.1 Data gaps

- Specific data on the mechanical properties of ovarian follicle ECM and how they compare to skin ECM is still lacking.
- No direct studies on electrospun silk fibroin scaffolds for ovarian follicle culture were found in the provided list.

### 7.2 Competence gaps

- Phase 1: Computational modeling (FEA, ABM)
- Phase 1: Machine learning
- Phase 1: Data analysis
- Phase 1: Basic knowledge of follicle biology
- Phase 2: Electrospinning and scaffold fabrication
- Phase 2: Follicle isolation and culture
- Phase 2: Live/dead staining and imaging
- Phase 2: qPCR
- Phase 2: Basic statistical analysis
- Phase 3: Advanced scaffold fabrication
- Phase 3: Follicle biology expertise
- Phase 3: Molecular biology techniques
- Phase 3: Advanced statistics
- Phase 3: Grant writing and publication

### 7.3 Epistemic gaps

- We do not know the optimal fiber diameter, alignment, and stiffness for follicle culture.
- We do not know whether the scaffold can support follicle growth to the antral stage.

## References

[1] L. Shea, T. Woodruff, et al. (2014). *Bioengineering the Ovarian Follicle Microenvironment*. DOI: [10.1146/annurev-bioeng-071813-105131](https://doi.org/10.1146/annurev-bioeng-071813-105131)
[2] Shuai Liu, Jiangming Yu, et al. (2023). *Biomimetic natural biomaterials for tissue engineering and regenerative medicine: new biosynthesis methods, recent advances, and emerging applications*. DOI: [10.1186/s40779-023-00448-w](https://doi.org/10.1186/s40779-023-00448-w)
[3] Miriam C Amores de Sousa, C. Rodrigues, et al. (2020). *Functionalization of Electrospun Nanofibers and Fiber Alignment Enhance Neural Stem Cell Proliferation and Neuronal Differentiation*. DOI: [10.3389/fbioe.2020.580135](https://doi.org/10.3389/fbioe.2020.580135)
[4] Huihua Yuan, Yaxian Zhou, et al. (2016). *A Newly Identified Mechanism Involved in Regulation of Human Mesenchymal Stem Cells by Fibrous Substrate Stiffness*. DOI: [10.1016/j.actbio.2016.06.034](https://doi.org/10.1016/j.actbio.2016.06.034)
[5] Tian Zhao, Ye Huang, et al. (2025). *Extracellular Matrix Signaling Cues: Biological Functions, Diseases, and Therapeutic Targets*. DOI: [10.1002/mco2.70281](https://doi.org/10.1002/mco2.70281)
[6] Weikang Hu, Zijian Wang, et al. (2020). *High Flexible and Broad Antibacterial Nanodressing Induces Complete Skin Repair with Angiogenic and Follicle Regeneration*. DOI: [10.1002/adhm.202000035](https://doi.org/10.1002/adhm.202000035)

## Annexes

### A. Detailed Reviewer Reports

#### Methodologist

- **Score**: 7.8/10 | **Verdict**: accept | **Confidence**: 0.85
- **Strengths**: The protocol is well-structured with a clear three-phase approach, starting with in silico validation to de-risk experimental work, which is a strong methodological practice.; The inclusion of multiple dependent variables (follicle survival and oocyte quality) and the use of both morphological and molecular markers provide a comprehensive assessment of outcomes.; The protocol explicitly addresses falsifiable predictions with defined thresholds and null hypotheses, which is a key element of rigorous scientific methodology.
- **Weaknesses**: The protocol lacks a clear description of randomization and blinding procedures, which could introduce selection and measurement biases.; The sample sizes are mentioned (e.g., 20-30 follicles per replicate) but no formal power analysis is provided to justify these numbers, raising concerns about statistical power.; The protocol does not fully address potential confounding variables such as scaffold degradation over time, which could affect long-term outcomes and reproducibility.
- **Questions**: How will you ensure randomization of follicles to different scaffold conditions and blinding of assessors during outcome evaluation to minimize bias?; What is the statistical power of your proposed sample sizes to detect the expected effect sizes (20% survival increase, 15% oocyte quality increase) with a significance level of 0.05?; How will you monitor and control for scaffold degradation during the 14-day culture period, and what impact might this have on the measured outcomes?
- **Recommendation**: The protocol is methodologically sound with a strong phased design and clear success criteria. However, to strengthen it further, I recommend incorporating explicit randomization and blinding procedures, conducting a formal power analysis to justify sample sizes, and adding a time-course assessment of scaffold degradation. These improvements will enhance internal validity and reproducibility, making the findings more robust for publication.

#### Domain Expert

- **Score**: 7.0/10 | **Verdict**: accept | **Confidence**: 0.8
- **Strengths**: The hypothesis leverages established principles of biomimetic scaffolds and mechanotransduction, which are well-supported in tissue engineering literature.; The proposed mechanism is plausible and builds on known integrin-mediated adhesion and YAP/TAZ signaling pathways.; The evidence base includes relevant reviews and analogous studies, providing a reasonable foundation for the hypothesis.
- **Weaknesses**: The hypothesis lacks specificity regarding optimal scaffold parameters (fiber diameter, alignment, stiffness) and their direct impact on follicle survival and oocyte quality.; The translation from skin wound healing (where silk fibroin scaffolds promoted follicle regeneration) to ovarian follicle culture is not straightforward due to differences in tissue microenvironment and follicle biology.; The evidence base is somewhat indirect; direct studies on electrospun silk fibroin scaffolds for ovarian follicle culture are missing, and the known unknowns are significant.
- **Questions**: How do the proposed scaffold parameters (fiber diameter 300-600 nm, alignment 0-90°, stiffness 1-10 kPa) specifically influence the mechanotransduction pathways in ovarian follicle cells, and are these parameters within the physiological range for ovarian tissue?; What is the degradation rate of silk fibroin scaffolds in vitro, and does it match the timeline of follicle development to the antral stage?; Can the scaffold support the complex 3D architecture of the follicle, including theca cell layers and basement membrane, without disrupting cell-cell communication?
- **Recommendation**: The hypothesis is promising and aligns with current trends in tissue engineering, but it requires further validation through systematic studies that vary scaffold parameters and assess follicle outcomes. I recommend focusing on optimizing the scaffold design and investigating the molecular mechanisms in a controlled in vitro system before in vivo translation.

#### Contrarian

- **Score**: 4.0/10 | **Verdict**: weak_reject | **Confidence**: 0.85
- **Strengths**: The hypothesis addresses a clinically relevant problem (improving follicle culture) and proposes a biomimetic approach that could enhance in vitro follicle development.; The use of electrospun silk fibroin scaffolds is a plausible strategy to mimic the native ECM, and the specified parameter ranges (fiber diameter, alignment, stiffness) indicate a thoughtful design.
- **Weaknesses**: FAIL REASON #1: The hypothesis assumes follicle cells will adhere to silk fibroin via integrins, but there is no evidence that silk fibroin supports integrin-mediated adhesion for ovarian follicle cells. If adhesion is poor, the entire mechanism collapses, and survival rates may not improve.; FAIL REASON #2: The predicted effect sizes (20-40% survival increase, 15-30% oocyte quality increase) are likely overestimated given the high variability in follicle culture outcomes and the lack of preliminary data. With typical sample sizes (n=3-5), these effects may not be statistically detectable, leading to false negatives or irreproducible results.; FAIL REASON #3: The hypothesis ignores the confounding effect of scaffold degradation products and potential immune responses. Silk fibroin degradation can release peptides that may be toxic or alter the culture environment, and the immune response in vitro is not addressed. These confounders could mask or negate any beneficial effects.
- **Questions**: How do you ensure that follicle cells will adhere to silk fibroin scaffolds, and what is the evidence that integrins bind to silk fibroin?; Given the lack of preliminary data, what is the expected variance in survival and oocyte quality measurements, and how will you achieve sufficient statistical power to detect the claimed 20-40% improvement?
- **Recommendation**: To strengthen the hypothesis, the authors should first perform pilot experiments to test follicle adhesion and viability on silk fibroin scaffolds, and to measure the actual effect sizes and variability. They should also include controls for scaffold degradation and immune responses, and consider using a range of scaffold parameters to identify the optimal conditions before claiming a causal mechanism.

#### Industrialist

- **Score**: 6.5/10 | **Verdict**: weak_accept | **Confidence**: 0.7
- **Strengths**: Market opportunity in fertility treatments: The global assisted reproductive technology (ART) market is projected to reach $45 billion by 2029, with a growing demand for improved in vitro fertilization (IVF) outcomes. This technology could address the unmet need for better follicle culture systems, potentially increasing success rates and reducing costs per live birth.; Competitive advantage: The use of electrospun silk fibroin scaffolds offers a tunable biomimetic environment that mimics native ECM better than current 2D culture or Matrigel-based systems. This could lead to higher follicle survival and oocyte quality, providing a significant edge over existing products like organ-on-chip devices or traditional culture dishes.
- **Weaknesses**: Barrier to entry: The technology is at an early TRL (3-4) with no validated clinical-grade product. Significant investment is needed for GMP-compliant scaffold manufacturing, sterilization, and regulatory approval (FDA/EMA) for clinical use, which could take 5-10 years and millions of euros.; Commercial risk: The market for follicle culture is niche, primarily in research and fertility clinics. Adoption may be slow due to the need for specialized equipment and expertise, and reimbursement may be limited. Additionally, competition from existing 3D culture systems (e.g., alginate hydrogels) could hinder market penetration.
- **Questions**: What is the specific target market segment (e.g., research labs, fertility clinics) and how will we achieve reimbursement or pricing to ensure a positive ROI within 5 years?; What is the IP landscape for silk fibroin scaffolds in reproductive biology, and can we secure strong patents to protect our technology from competitors?
- **Recommendation**: Proceed with Phase 1 and 2 validation, but simultaneously conduct a market analysis and engage with key opinion leaders in reproductive medicine to refine the value proposition. If Phase 2 shows promising results, consider licensing the technology to an established ART company or forming a spin-off with a clear regulatory pathway.

#### Funding Strategist

- **Score**: 7.5/10 | **Verdict**: accept | **Confidence**: 0.8
- **Strengths**: Clear mechanistic hypothesis with defined parameters (fiber diameter, alignment, stiffness) and measurable outcomes (follicle survival, oocyte quality).; Phase-gated protocol with explicit GO/NO-GO criteria reduces risk for funders and demonstrates scientific rigor.; Interdisciplinary approach combining biomaterials, tissue engineering, and reproductive biology, with potential for high-impact publications.
- **Weaknesses**: TRL is low (1-2) as the hypothesis is at the initial validation stage; no in vivo data or clinical translation pathway.; Limited consortium expertise in reproductive biology and clinical IVF may be needed to strengthen translational relevance.; Budget may be insufficient for full Phase 3 validation, which could require more resources for animal models or advanced imaging.
- **Questions**: How will you access human ovarian follicles or oocytes for validation, and what ethical approvals are in place?; What is the novelty compared to existing 3D culture systems (e.g., alginate, Matrigel) and how will you differentiate?; Have you considered the scalability of electrospun silk fibroin scaffolds for clinical use, and what are the regulatory hurdles?
- **Recommendation**: Target the ERC Starting Grant for its emphasis on high-risk, high-gain research and the PI's potential. Simultaneously, apply to the ANR Jeunes Chercheuses et Jeunes Chercheurs (JCJC) for national funding to support preliminary data. For a more applied angle, consider the Horizon Europe EIC Pathfinder Open to fund the proof-of-concept and potential innovation.

### B. Semantic Scholar Search Queries

- [novelty] `silk fibroin electrospun ovarian follicle` — Direct search for the core hypothesis combining silk fibroin scaffolds with ovarian follicle culture
- [novelty] `electrospun scaffold follicle survival oocyte quality` — Search for existing studies applying electrospun scaffolds to improve follicle survival and oocyte quality
- [novelty] `biomimetic scaffold ovarian follicle microenvironment` — Search for biomimetic scaffolds designed to mimic the ovarian follicle microenvironment
- [novelty] `tissue engineering principles follicle culture` — Search for application of tissue engineering principles to follicle culture
- [evidence] `extracellular matrix mechanical cues follicle development` — Find evidence on how ECM mechanical cues influence follicle development
- [evidence] `electrospun fiber stiffness stem cell differentiation` — Find evidence on how electrospun fiber stiffness affects stem cell differentiation, relevant to follicle cells
- [evidence] `basement membrane components follicle atresia` — Find evidence on the role of basement membrane components in preventing follicle atresia
- [evidence] `3D scaffold follicle stroma interactions` — Find evidence on how 3D scaffolds maintain follicle-stroma interactions for follicle growth
- [cross_domain] `electrospun scaffold skin wound healing` — Find precedents in skin tissue engineering using electrospun scaffolds
- [cross_domain] `biomimetic ECM scaffold ovarian tissue engineering` — Find interdisciplinary precedents applying biomimetic ECM scaffolds to ovarian tissue engineering
- [cross_domain] `mechanical properties scaffold cell behavior` — Find general principles of how scaffold mechanical properties influence cell behavior across tissues

---

*Generated by SPORE (Systeme de Production d'Opportunites de Recherche par Exploration) on 2026-08-24*